A biopharmaceutical professional recently received approval for their EB2 National Interest Waiver (NIW) application, despite lacking a PhD and publications. The individual, who has over 15 years of experience in the biopharma industry and holds a Master of Science in Biotechnology, filed their NIW petition in 2024 and upgraded it to premium processing in late 2025.
Key Details:
- Application filed: EB2 NIW in 2024, upgraded to premium processing in Q4 2025.
- Received a Request for Evidence (RFE) in November 2025 focusing on Prongs 1 and 3 of the NIW criteria.
- Submitted a comprehensive response including an endeavor statement, a detailed response letter, and an independent expert letter.
- Successfully demonstrated national importance and a well-positioned track record to advance the proposed endeavor.
This case highlights the possibility of obtaining NIW approval without a PhD or publications, provided that applicants can effectively demonstrate their work’s national significance and their capability to advance it.
Need help with your immigration case? Visit QuickFiling.us for professional immigration services.
Source: r/EB2_NIW